Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
+$883M |
| 2 |
Boeing
BA
|
+$345M |
| 3 |
Salesforce
CRM
|
+$344M |
| 4 |
DexCom
DXCM
|
+$301M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$253M |
Top Sells
| 1 |
DRE
Duke Realty Corp.
DRE
|
+$779M |
| 2 |
Chevron
CVX
|
+$585M |
| 3 |
Home Depot
HD
|
+$264M |
| 4 |
Chubb
CB
|
+$263M |
| 5 |
PepsiCo
PEP
|
+$263M |
Sector Composition
| 1 | Technology | 16.53% |
| 2 | Healthcare | 15.07% |
| 3 | Financials | 14.94% |
| 4 | Industrials | 11.6% |
| 5 | Consumer Discretionary | 10.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLYM
3951
Climb Bio
CLYM
$155M
| $242K | ﹤0.01% |
67,685
-4,380
| -6% | -$15.7K |
|
|
ADAP
3952
Adaptimmune Therapeutics
ADAP
$42.9M
| $240K | ﹤0.01% |
164,659
+153,255
| +1,344% | +$223K |
|
|
AKYA
3953
DELISTED
Akoya BioSciences
AKYA
| $240K | ﹤0.01% |
25,084
-215,149
| -90% | -$2.06M |
|
3954
Levi Strauss
LEVI
$9.05B
| $240K | ﹤0.01% |
15,470
-1,661,896
| -99% | -$25.8M |
|
3955
Latham Group
SWIM
$895M
| $240K | ﹤0.01% |
74,570
-1,077,878
| -94% | -$3.47M |
|
|
AUTL
3956
Autolus Therapeutics
AUTL
$357M
| $239K | ﹤0.01% |
125,650
+46,640
| +59% | +$88.7K |
|
3957
Landmark Bancorp
LARK
$156M
| $239K | ﹤0.01% |
11,636
-2,225
| -16% | -$45.7K |
|
3958
First Northwest Bancorp
FNWB
$66M
| $238K | ﹤0.01% |
15,490
-4,761
| -24% | -$73.2K |
|
3959
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$21.4B
| $238K | ﹤0.01% |
4,782
-1,394
| -23% | -$69.4K |
|
3960
Iris Energy
IREN
$10.7B
| $238K | ﹤0.01% |
190,546
+29,422
| +18% | +$36.7K |
|
3961
Sphere Entertainment
SPHR
$2.14B
| $237K | ﹤0.01% |
5,271
-446
| -8% | -$20.1K |
|
3962
Atlanta Braves Holdings Series A
BATRA
$2.84B
| $236K | ﹤0.01% |
7,239
-9,342
| -56% | -$305K |
|
3963
Green Plains
GPRE
$645M
| $235K | ﹤0.01% |
7,713
-32,234
| -81% | -$982K |
|
|
BRSP
3964
BrightSpire Capital
BRSP
$757M
| $234K | ﹤0.01% |
37,548
-73,038
| -66% | -$455K |
|
|
ADAM
3965
Adamas Trust
ADAM
$667M
| $234K | ﹤0.01% |
22,852
-13,111
| -36% | -$134K |
|
3966
United Fire Group
UFCS
$804M
| $234K | ﹤0.01% |
8,558
-451
| -5% | -$12.3K |
|
3967
Research Frontiers
REFR
$47.1M
| $233K | ﹤0.01% |
121,584
-53,630
| -31% | -$103K |
|
3968
DXP Enterprises
DXPE
$1.83B
| $232K | ﹤0.01% |
8,412
-130,570
| -94% | -$3.6M |
|
3969
Euroseas
ESEA
$438M
| $231K | ﹤0.01% |
15,413
-27,196
| -64% | -$408K |
|
3970
iShares MSCI Turkey ETF
TUR
$173M
| $231K | ﹤0.01% |
6,254
-14,435
| -70% | -$533K |
|
|
XHR
3971
Xenia Hotels & Resorts
XHR
$1.4B
| $231K | ﹤0.01% |
17,540
-826,872
| -98% | -$10.9M |
|
3972
Advantage Solutions
ADV
$590M
| $230K | ﹤0.01% |
110,469
-799,755
| -88% | -$1.67M |
|
3973
Stock Yards Bancorp
SYBT
$2.21B
| $230K | ﹤0.01% |
+3,544
| New | +$230K |
|
|
VIA
3974
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $230K | ﹤0.01% |
8,991
+921
| +11% | +$23.6K |
|
3975
Revolve Group
RVLV
$1.68B
| $229K | ﹤0.01% |
10,276
-452,357
| -98% | -$10.1M |
|